Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPBARBOSA, EduardoEIBEL, BrunaFEITOSA, Audes D. M.BRANDAO, Andrea A.BORTOLOTTO, Luiz A.NEVES, Mario F. T.V, Jose F. MartinSPINELLI, Antonio C. S.CESTARIO, Elizabeth E. S.CAMPANA, Erika M. G.TOLEDO, Juan C. Y.POVOA, Rui M. S.BEANEY, ThomasSTER, Anca ChisPOULTER, Neil R.MOTA-GOMES, Marco A.BARROSO, Weimar Kunz Sebba2021-04-152021-04-152020EUROPEAN HEART JOURNAL SUPPLEMENTS, v.22, n.H, p.H26-H29, 20201520-765Xhttps://observatorio.fm.usp.br/handle/OPI/40142Hypertension is a pathology of high prevalence in the world. In Brazil, it is the main risk factor for the major cause of death in the country, coronary heart disease. The May Measurement Month Campaign in 2018 (MMM18) included a population with resentation from all Brazilian states and reflects some of the characteristics of pertension in Brazil. Questionnaire data were collected and three measures of pressure (BP) were performed. The sample consisted of 12 413 individuals, 59.1% were white, 51.3% were women. The average age was 54. +/- 16.0 years. Diabetes was present in 11.6%, previous myocardial infarction in 5.9%, and previous stroke in 2.7%. Current smokers were 9.3% and 12.4% were regular drinkers. The average body mass index was 27.3 +/- 4.5 kg/m(2). After multiple imputations, 67.9% were hypertensive (>140/90 mmHg). Of the individuals who were not taking antihypertensive medication, 27.9% were hypertensive and of those taking antihypertensive medication, 40.3% were uncontrolled. Systolic BP increased with age. The MMM18 campaign demonstrated a large number of unknown hypertensives and a high rate of uncontrolled hypertension in Brazil, unfortunately in keeping with 2017 findings.engopenAccessMMM18HypertensionBrazilarticleCopyright OXFORD UNIV PRESS10.1093/eurheartj/suaa022Cardiac & Cardiovascular Systems1554-2815